Alteon, BioRap Technologies Ltd., Oxis deal

ALT and BioRap expanded a 2005 deal to give ALT rights to all BioRap’s cardiovascular diagnostic technologies. BioRap will receive an upfront payment and research funding

Read the full 261 word article

User Sign In